It had posted net profit of Rs 130 crore for the January- March period of the previous fiscal, the company said in a BSE filing.
Total income from operations stood at Rs 1,499 crore for the quarter under consideration, compared with Rs 1,154 crore for the year-ago period.
For the entire 2015-16 fiscal, the consolidated net profit of the company was at Rs 1,722 crore. It was Rs 751 crore in the year-ago fiscal.
"The figures for the quarter ended December 31, 2015 and March 31, 2016 are after giving effect of scheme of amalgamation while figures for the corresponding quarters are before giving effect of amalgamation," Torrent Pharma said.
Hence, the figures of the corresponding period and previous year are not comparable with the figures of the current period, it added.
In a separate filing, the company said its board after considering the distribution of interim dividend and special interim dividend of Rs 20 and Rs 15 (total Rs 35 per share) respectively per equity share of Rs 5 each for the financial year 2015-16, did not recommend distribution of any further dividend.
You’ve reached your limit of {{free_limit}} free articles this month.
Subscribe now for unlimited access.
Already subscribed? Log in
Subscribe to read the full story →
Smart Quarterly
₹900
3 Months
₹300/Month
Smart Essential
₹2,700
1 Year
₹225/Month
Super Saver
₹3,900
2 Years
₹162/Month
Renews automatically, cancel anytime
Here’s what’s included in our digital subscription plans
Exclusive premium stories online
Over 30 premium stories daily, handpicked by our editors


Complimentary Access to The New York Times
News, Games, Cooking, Audio, Wirecutter & The Athletic
Business Standard Epaper
Digital replica of our daily newspaper — with options to read, save, and share


Curated Newsletters
Insights on markets, finance, politics, tech, and more delivered to your inbox
Market Analysis & Investment Insights
In-depth market analysis & insights with access to The Smart Investor


Archives
Repository of articles and publications dating back to 1997
Ad-free Reading
Uninterrupted reading experience with no advertisements


Seamless Access Across All Devices
Access Business Standard across devices — mobile, tablet, or PC, via web or app
